AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06021847 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Ozonated water
Description: ozonated water was prepared with a concentration of (2-4 mg/l) ozone for 1 min. in a 25 mg of double distilled water 37o C employing an Ozone generator (Ozone generator type N 1888A, China.)
Study NCT06021847 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Chlorhexidine mouthwash
Description: Commercial available chlorhexidine mouthwash in the market was used.
Study NCT05326074 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Animal assisted therapy cohort
Description: A therapy dog will be present in the room during the routine outpatient psychiatric visit.
Study NCT06240793 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: unilateral transforaminal epidural steroid block
Description: unilateral transforaminal epidural steroid block
Study NCT06240793 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: bilateral transforaminal epidural steroid block
Description: bilateral transforaminal epidural steroid block
Study NCT06244524 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High indoor CO2 exposure
Description: The participants will stay and sleep for eight hours in a closed bedroom.
Study NCT05316519 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Transcutaneous Vagus Nerve Stimulation
Description: Visuomotor task training with transcutaneous stimulation targeting landmark that activates biomarker
Study NCT05316519 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Transcutaneous Vagus Nerve Stimulation
Description: Visuomotor task training with transcutaneous stimulation targeting landmark that activates biomarker
Study NCT05845411 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindful Eating
Description: Nutritional advice through expository content, group discussion, and exchange of experiences on self-knowledge, food awareness, and relationship with food and the body.
Study NCT05845411 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard dietary treatment
Description: Hypocaloric dietary prescription and nutritional education.
Study NCT05483595 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Chinese herbal medicine FYTF-919
Description: Oral liquid 10ml
Study NCT05263622 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Split-mouth administration for group B
Description: * Plaque disclosing agent application and instructions to patients for a correct oral hygiene;~* Airflow deplaquing with EMS handpiece (quadrants Q1 and Q3) and with Mectron handpiece (quadrants Q2 and Q4)~* Calculus removal with EMS ultrasound handpiece (Q1 and Q3) and with Mectron handpiece (Q2 and Q4)
Study NCT05263622 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Split-mouth administration for group A
Description: * Plaque disclosing agent application and instructions to patients for a correct oral hygiene;~* Airflow deplaquing with EMS handpiece (quadrants Q2 and Q4) and with Mectron handpiece (quadrants Q1 and Q3)~* Calculus removal with EMS ultrasound handpiece (Q2 and Q4) and with Mectron handpiece (Q1 and Q3)
Study NCT06138236 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Collagen hydrolyzed peptides
Description: infiltration near the heal spur of 2ml of Arthrys
Study NCT06291064 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Cyclophosphamide is given by intravenous (IV) infusion once every 3 weeks for 4 doses total (12 weeks). It will be given together with Epirubicin.
Study NCT06291064 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Epirubicin
Description: Epirubicin is given by intravenous (IV) infusion once every 3 weeks for 4 doses total (12 weeks). It will be given together with Cyclophosphamide.
Study NCT06291064 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Docetaxel
Description: Docetaxel is given by intravenous (IV) infusion once every 3 weeks for 4 doses total (12 weeks). It will be given together with Carboplatin. Dosing will start after treatment with Epirubicin and Cyclophosphamide (EC) is completed.
Study NCT06291064 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Carboplatin is given by intravenous (IV) infusion once every 3 weeks for 4 doses total (12 weeks). It will be given together with Docetaxel. Dosing will start after treatment with EC is completed.
Study NCT06291064 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Breast Surgery
Description: Participants will undergo breast surgery after completing dosing with Carboplatin and Docetaxel to remove any remaining cancer in the breast.
Study NCT06291064 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capecitabine
Description: Capecitabine is a pill that will be taken by mouth daily for 6 months after surgery is completed.
Study NCT06388967 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: PANcreatic cancer Exosome Early detectiON (PANXEON)
Description: This test will utilize quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) to quantify the expression levels of 5 cell-free and 8 exosome-miRNAs in plasma samples obtained from patients with pancreatic ductal adenocarcinoma and from individuals without it
Study NCT05715983 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Bascom II procedure
Description: Buttocks are strapped apart with wide adhesive tape. The area is prepared using antiseptic solution twice. Solution of brilliant green with 3% hydrogen peroxide was injected in all orifices to visualize all tracts and sinuses. The proposal area of incision is marked nearby sinus tract openings and the skin with lateralization on one side of the cleft. A vertical-orientated incision of the skin and subcutaneous fat around the primary and secondary orifices is made using a scalpel or a monopolar electrocautery. The sinus tract is excised in en-block till unchanged subcutaneous tissue. The wound is irrigated with antiseptic solution. If postoperative wound is larger than 5 cm then a silicone draining tube is placed through the contraperature in the upper corner. The wound is closed by interrupted sutures Vicryl/Polysorb 2/0 3/0 layer by layer. Aseptic dressing is applied to the closed wound.
Study NCT05715983 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: SiLaC
Description: Buttocks are strapped apart with wide adhesive tape. The area is prepared using antiseptic solution twice. Solution of brilliant green with 3% hydrogen peroxide is injected in all orifices to visualize all tracts and sinuses. All visible orifices are excised with a scalpel or dermo punch. After that hairs are removed from the sinus by Volkmann curette. A metallic stylet is used to determine the length and direction of the different tracts. Then laser destruction of the sinus is performed with FiberLase VT laser, wavelength 1460 or 1520 nm, the laser energy 10-12 Watts. The fiber delivers energy homogeneously in a continuous way. Hemostasis by electrocautery. The wound is washed with povidone-iodine solution. Aseptic dressing is applied.
Study NCT06506851 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: AR-based Training with Microsoft HoloLens 2®
Description: Practical nurses in this group receive AR-based training using Microsoft HoloLens 2®. This training method incorporates augmented reality technology to provide immersive and interactive learning experiences, enhancing their proficiency in device utilization.
Study NCT06084897 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TP (Paclitaxel with cisplatin or carboplatin) or PF (Fluoropyrimidine with cisplatin or carboplatin) regimen depended on investigator's choice.
Description: A maximum of six cycles was recommended for chemotherapy.~* Fluoropyrimidine (fluorouracil or capecitabine) with carboplatin or cisplatin;~* Paclitaxel (or Albumin-bound paclitaxel) with carboplatin or cisplatin.
Study NCT06084897 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: PD-1 inhibitor
Description: Nivolumab or Pembrolizumab or Tislelizumab or Serplulimab or Toripalimab or Sintilimab or Camrelizumab
Study NCT06084897 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Consolidation Radiation
Description: IMRT/VMAT technique. Patients receive radiotherapy once daily, 5 days a week for an average of 5 weeks. Radiotherapy is delivered to achieve a dosage of 49.22Gy/23f or 50Gy/25f to PGTV for lymphnode metastasis only patients and 40.66Gy/19f or 40Gy/20f for organ metastasis patients. Radiation treatment is planned after chemotherapy completed.
Study NCT06084897 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Salvage Radiation
Description: IMRT/VMAT technique. Patients receive radiotherapy once daily, 5 days a week for an average of 5 weeks. Radiotherapy is delivered to achieve a dosage of 49.22Gy/23f or 50Gy/25f to PGTV for lymphnode metastasis only patients and 40.66\~49.22Gy/19f \~23f or 40\~50Gy/20\~25f for organ metastasis patients. Radiation treatment is planned after disease progression when recommended by multidisciplinary team.
Study NCT05004584 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Wheat home-based appetite assessment
Description: Home-based appetite assessment with diet based on wheat cereal products.
Study NCT05004584 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Rye home-based appetite assessment
Description: Home-based appetite assessment with diet based on rye cereal products.
Study NCT05004584 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Wheat clinic-based appetite assessment
Description: Clinic-based appetite assessment with diet based on wheat cereal products.
Study NCT05004584 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Rye clinic-based appetite assessment
Description: Clinic-based appetite assessment with diet based on rye cereal products.
Study NCT05004584 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Rye/Wheat clinic-based appetite assessment with blood sampling
Description: Clinic-based appetite assessment with diet based on rye or wheat cereal products and continuous blood sampling.
Study NCT06104995 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Interventional video
Description: The educational video comprises of health care professionals explaining the durability of the back against the popular belief that the back is fragile and the multifactorial nature of back pain.
Study NCT06104995 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Control video
Description: The control video is a neutral video with no content addressing back beliefs (fragility and need for protection).
Study NCT06506851 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Traditional Guideline-based Self-Learning
Description: Practical nurses in this group follow traditional guideline-based self-learning methods without augmented reality technology. They rely on conventional educational materials and guidelines for learning device utilization skills.
Study NCT06248190 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: ENHANCE intervention (health systems)
Description: The intervention tools include a consolidated clinical decision support tool, health education posters, waiting room talks, medication list for treatment literacy and a patient health diary. Training session are delivered at all intervention sites and include 1 facility team session to introduce the ENHANCE study to the whole team; 3 clinical sessions for nurses and doctors; 2 sessions for community health workers and health promoters; Maintenance sessions to keep the ENHANCE intervention going for at least 12 months
Study NCT05660018 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: active rTMS first, then sham rTMS
Description: Active rTMS is delivered on the first visit, then sham rTMS is delivered on the second visit.
Study NCT05660018 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: sham rTMS first, then active rTMS
Description: Sham rTMS is delivered on the first visit, then active rTMS is delivered on the second visit.
Study NCT04899661 — intervention group
Intervention type: DRUG
Intervention: Molidustat (Musredo, BAY85-3934)
Description: Tablets, administered orally at the discretion of investigators
Study NCT05504239 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Teneligliptin (as Teneligliptin Hydrobromide) 20 Mg Oral Tablet
Description: To be orally administered once daily
Study NCT05504239 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Teneligliptin Placebo Oral Tablet
Description: To be orally administered once daily
Study NCT05492578 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amlitelimab
Description: Pharmaceutical form: Solution for injection Route of administration: Subcutaneous
Study NCT05492578 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Topical corticosteroids
Description: Pharmaceutical form: Topical Route of administration: Topical
Study NCT05492578 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Topical calcineurin inhibitors
Description: Pharmaceutical form: Topical Route of administration: Topical
Study NCT05492578 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral corticosteroids
Description: Pharmaceutical form: Oral Route of administration: Oral
Study NCT06029517 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Education Intervention
Description: Receive Indigneous SIPin intervention
Study NCT05588908 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection 100 mg (phase Ib)
Description: 100 mg subcutaneous (s.c) once
Study NCT05588908 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection 200 mg (phase Ib)
Description: 200 mg subcutaneous (s.c) once
Study NCT05588908 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection 300 mg (phase Ib)
Description: 300 mg subcutaneous (s.c) once
Study NCT05588908 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection 200 mg (phase II)
Description: one s.c. injection of SSGJ-613 once, on Day 1.
Study NCT05838794 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mckenzie exercise for neck
Description: The McKenzie protocol will be used to manage extension, rotation, and lateral flexion dysfunctions in patients with non-specific neck pain. An experienced physical therapist will perform the protocol 3 times a week for 6 weeks, tailoring exercises to each patient's individual needs based on limited and painful directions of movement. Exercises include retraction, extension, rotation, lateral flexion, and overpressure techniques. Patients will receive education on posture and body mechanics, and exercises will be progressed over time as the patient improves.
Study NCT05838794 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Mckenzie exercise for neck
Description: The McKenzie protocol will be used to manage extension, rotation, and lateral flexion dysfunctions in patients with non-specific neck pain. An experienced physical therapist will perform the protocol 3 times a week for 6 weeks, tailoring exercises to each patient's individual needs based on limited and painful directions of movement. Exercises include retraction, extension, rotation, lateral flexion, and overpressure techniques. Patients will receive education on posture and body mechanics, and exercises will be progressed over time as the patient improves.
Study NCT05838794 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Stabilization exercise
Description: Cervical and scapulothoracic stabilization exercises will be performed by an experienced physical therapist 3 times a week for 6 weeks, with each session including a warm-up, stabilization exercises, and cool-down and stretching exercises. Postural education will be provided using mirrors to find a neutral balanced position, and the cervical bracing technique with deep neck flexor activation will be used to stabilize the cervical spine. Upper extremity range of motion exercises and cervical dynamic isometric exercises with elastic resistive bands will also be performed. Scapulothoracic stabilization exercises will include specific exercises for muscles affecting scapular orientation related to neck pain, using latex bands with mild or medium tension.
Study NCT04746781 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mobile 360° Video intervention
Description: Using 360° Videos to educate participants about the effect of diabetes.
Study NCT04746781 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motivation and Problem Solving (MAPS)
Description: Using Motivation and Problem Solving to help people enroll in the Diabetes Prevention Program.
Study NCT04746781 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Risk notification/education
Description: Sending participants (all of whom meet the diagnostic criteria for prediabetes) educational information about the condition.
Study NCT04746781 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Risk notification/education
Description: Sending participants (all of whom meet the diagnostic criteria for prediabetes) educational information about the condition.
Study NCT04701749 — intervention group
Intervention type: DEVICE
Intervention: Percutaneous left atrial closure
Description: Percutaneous left atrial closure was performed under general anesthesia with angiographic control and transesophageal echocardiography. The procedure takes between 15 and 20 minutes. This begins with a right femoral venipuncture, progression of the guide in the right atrium allowing atrial trans-septal puncture to catheterize the left atrium. A nitinol prosthesis is implanted (Boston Watchman) at the ostium of the left auricle between the left superior pulmonary vein and the circumflex artery. After a tensile test verifying the stability of the prosthesis, the absence of peri-prosthetic leakage is verified by ETO and angiographic control. The patient is monitored 48 hours before discharge to eliminate the appearance of pericardial effusion and prosthetic embolization. Aspirin 75 mg monotherapy is started the same day with stopping anticoagulation.
Study NCT04701749 — intervention group
Intervention type: OTHER
Intervention: No Percutaneous left atrial closure
Description: No Percutaneous left atrial closure
Study NCT04885465 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: web-based psychoeducational support
Description: Caregivers in the experimental group will have access to psycho-educational support through a web-based plattform during 3 months.
Study NCT05588908 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection low dose 300 mg (phase II)
Description: one s.c. injection of SSGJ-613 once, on Day 1.
Study NCT04400227 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Family Talk
Description: Family Talk is an evidence-based, parent-youth dyadic approach that uses psychoeducation and skills building to help families make meaning of a parent's adversity, increase resilience, and improve family functioning.~The Family Talk model comprises two components: the first involves a series of cognitive-behavioral techniques to bolster problem solving and communication skills among family members; the second involves a facilitated family meeting to develop a shared narrative for discussing each family member's experience of the parent's illness.
Study NCT05588908 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Compound Betamethasone Injection (phase II)
Description: 1 mL i.m. once on Day 1
Study NCT06029517 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Interview
Description: Complete interviews
Study NCT06029517 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Discussion
Description: Attend focus groups
Study NCT05614752 — intervention group
Intervention type: DRUG
Intervention: Fexuprazan
Description: Fexuclue Tablet 40mg
Study NCT06295796 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MK-8527
Description: Oral Capsule
Study NCT06206707 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Faecal Microbiota Transplantation (FMT)
Description: Capsule FMT
Study NCT06206707 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo capsules
Study NCT04951180 — intervention group
Intervention type: OTHER
Intervention: Demographic data and MRI images extraction
Description: The data were retrospectively extracted pre- and postoperatively after hip arthroscopy. The prognosis of the surgery was evaluated through MRI images.
Study NCT05264740 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motivational interviewing
Description: The intervention group will receive motivational interviewing sessions with a trained study nurse plus educational material
Study NCT05264740 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Educational materials
Description: The control group will receive educational material only.
Study NCT06175754 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Laser ablation
Description: Examination, photographing, inclusion in the study, signing of informed consent, randomization, diameter measurement, laser
Study NCT06175754 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Laser with Sclerotherapy
Description: Examination, photographing, inclusion in the study, signing of informed consent, randomization, diameter measurement, laser plus sclerotherapy
Study NCT06175754 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Sclerotherapy
Description: Examination, photographing, inclusion in the study, signing of informed consent, randomization, diameter measurement, sclerotherapy
Study NCT04882878 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo will be administered intravenously.